Wilmington, N.C.-based PPD Inc. and Microsoft Corp., based in Seattle, announced they will implement a technology solution designed to improve efficiency in managing U.S. Food and Drug Administration-mandated Risk Evaluation and Mitigation Strategy (REMS) programs.
The technology will be based on Microsoft Amalga Unified Intelligence System (UIS), a data aggregation platform that gives healthcare professionals access to the information they need, and Microsoft HealthVault, a personal health application platform that allows consumers gather, store, and share health information online.
When completed, this technology solution will provide biopharmaceutical companies with a long-term system for managing operational components of REMS programs while tracking large amounts of information collected from multiple sources, including the patient, healthcare provider and pharmacy.
The solution will integrate PPD's strategic, scientific, operational and regulatory capabilities in designing and implementing comprehensive REMS and risk management programs with Microsoft's global software development expertise.
ID 174288183 © Transversospinales | Dreamstime.com
ID 106651169 © Vaeenma | Dreamstime.com
